Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT04468061 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT04468061 is currently recruiting participants. This clinical trial study for triple negative breast cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04468061 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04468061 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.